Correlation Between Cadrenal Therapeutics, and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and SAB Biotherapeutics, you can compare the effects of market volatilities on Cadrenal Therapeutics, and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and SAB Biotherapeutics.
Diversification Opportunities for Cadrenal Therapeutics, and SAB Biotherapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cadrenal and SAB is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and SAB Biotherapeutics
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cadrenal Therapeutics, Common is 3.66 times less risky than SAB Biotherapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 5.00 in SAB Biotherapeutics on August 30, 2024 and sell it today you would earn a total of 1.83 from holding SAB Biotherapeutics or generate 36.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 86.96% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. SAB Biotherapeutics
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| SAB Biotherapeutics |
Cadrenal Therapeutics, and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and SAB Biotherapeutics
The main advantage of trading using opposite Cadrenal Therapeutics, and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.The idea behind Cadrenal Therapeutics, Common and SAB Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |